MedPath

Meiziya Kang M5 Capsules

Registration Number: MAL22056060TC

Approved
Approval ID

db07f6fe4db681b6

Registration Number

MAL22056060TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

28 CapsulesAvailable
Package Size: 28 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

Poria cocosActive
Monograph: poria cocos
Uncaria rhynchophyllaActive
Monograph: uncaria rhynchophylla
Glycyrrhiza uralensisActive
Lycium barbarumActive
Monograph: lycium barbarum
Chrysanthemum morifoliumActive
Monograph: chrysanthemum morifolium
Bupleurum chinenseActive
Monograph: bupleurum chinense

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meiziya Kang M5 Capsules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform